Tarry AhujaTARRY AHUJA, PhD (Neuroscience) is the inaugural Director of the new Post-Market Drug Evaluation (PMDE) Program at the Canadian Agency for Drugs and Technology in Health (CADTH), the leading HTA agency for Canada. He is also the architect of CoLab which is a pan-Canadian evidence-generation network made up of experts in applied research, drug evaluation methodologies, and data analysts. Together, PMDE and CoLab are responsible for providing evidence on the post-market safety and effectiveness of drugs approved for use in Canada for senior decision-makers. While at CADTH, he was also the Manager of Program Development in Pharmaceutical Reviews and Sr. RWE Advisor establishing the RWE Steering Committee with national representation which has recently established Guiding Principles for use of real-world evidence in Canada. Prior to this he was a senior medical real-world evidence scientist for Eli Lilly for Europe and Canada leading development of observational research and real-world data assets with an international perspective for novel pharmacological interventions. He has worked for over 10 years in the hospital setting in the area of sleep disorders and he has over 10 years of clinical research in the areas of otolaryngology, Alzheimer’s, stroke and ischemia with the National Research Council of Canada with over 50 publications and contributions. He is also currently a lecturer at Carleton University teaching “Biological Foundations of Addictions” and “Health Psychology” and teaches the medical school learning stream of “Behavioural Health” on the global online learning platform Lecturio. He graduated with a PhD in Neuroscience with a specialty in electrophysiology and pharmacology from Carleton University, Ottawa, Canada.